Clinical evolution

Icon eyeing China

Icon eyeing China

By Nick Taylor

Icon is looking to expand its bioanalytical capacity in Asia, notably in China, and bolster its genomics, proteomics and cell-based assay capabilities, according to a VP who discussed diversification of the business.

Pharma turning to SAAS

Pharma turning to SAAS

By Nick Taylor

Pharma’s increasing collaboration and budget cuts have made hosted software more attractive to companies, according to Symyx which has made its lab notebook available on this platform.

Follow us

Products

View more

Webinars